EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY

被引：0
|
作者：
Saliba, Faouzi [1 ]
De Simone, Paolo [2 ]
Nevens, Frederik [3 ]
De Carlis, Luciano [4 ]
Metselaar, Herold [5 ]
Beckebaum, Susanne [6 ]
Jonas, Sven [7 ]
Sudan, Debra [8 ]
Fischer, Lutz [9 ]
Fung, John J. [10 ]
Jiang, Hai [11 ]
Junge, Guido [12 ]
机构：
[1] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[2] Azienda Osped Univ Pisana, Pisa, Italy
[3] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] Univ Hosp Rotterdam, Erasmus MC, Rotterdam, Netherlands
[6] Univ Hosp Essen, Essen, Germany
[7] Univ Med Ctr Leipzig, Leipzig, Germany
[8] Duke Univ, Med Ctr, Durham, NC USA
[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[11] Novartis Pharmaceut, E Hanover, NJ USA
[12] Novartis Pharma AG, Basel, Switzerland
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1430A / 1431A
页数：2
相关论文
共 50 条
  • [41] Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
    De Simone, P.
    Detry, O.
    Kintmalm, G.
    Goss, J.
    McCormick, P.
    Rossi, M.
    Moya, A.
    Lopez, P.
    Junge, G.
    Dong, G.
    Joseph, D.
    Duvoux, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 169 - 170
  • [42] Efficacy and Safety of Everolimus Based Immunosuppression in HCV Positive De Novo Liver Transplant Recipients
    Saliba, F.
    De Simone, P.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fung, J.
    Fischer, L.
    Huang, M. A.
    Foltys, D.
    Wang, Y.
    Sips, C.
    Lopez, P.
    Nevens, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 125 - 126
  • [43] HEPHAISTOS STUDY: DESIGN AND BASELINE DATA FROM EARLY INITIATION OF EVEROLIMUS-BASED TACROLIMUS REDUCTION IN DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nashan, B.
    Schemmer, P.
    Braun, F.
    Dworak, M.
    Wimmer, P.
    Schlitt, H.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 316 - 316
  • [44] EFFICACY AND SAFETY OF EARLY USE OF REDUCED TACROLIMUS IN COMBINATION WITH EVEROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVERTRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA
    Schemmer, Peter
    Braun, Felix
    Schlitt, Hans J.
    Pascher, Andreas
    Klein, Christian-Georg
    Neumann, Ulf
    Kroeger, Irena
    Wimmer, Peter
    Nashan, Bjoern
    TRANSPLANT INTERNATIONAL, 2019, 32 : 218 - 219
  • [45] Safety and Efficacy Profile of Everolimus With Reduced Tacrolimus in Living Donor Liver Transplant Recipients-12-month Results From the Pivotal H2307 Study
    Maluf, Daniel
    Jeng, Long-Bin
    Lee, Sung Gyu
    Soin, Arvinder S.
    Lee, Wei Chen
    Emond, Jean
    Lim, Kieron B.
    Lopez, Patricia M.
    Kochuparampil, Jossy
    Sips, Carole A.
    Kaneko, Shuhei
    Grant, David
    HEPATOLOGY, 2017, 66 : 901A - 901A
  • [46] Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial
    Fung, J.
    Chavin, K.
    Moysyuk, Y.
    Orloff, S.
    Yantorno, S.
    Jones, R.
    Neuhaus, P.
    Dong, G.
    Lopez, P.
    Junge, G.
    Nevens, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 118 - 118
  • [47] Safety of Early Everolimus in De Novo Heart Transplant Recipients: Interim Analysis of the Randomized Study EVERHEART.
    Potena, L.
    Barberini, F.
    Boffini, M.
    Maiello, C.
    Pedrazzini, G.
    Faggian, G.
    Gerosa, G.
    Lilla, P.
    Marraudino, N.
    Corda, M.
    Bernazzali, S.
    Guarisco, R.
    Livi, U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 93 - 93
  • [48] Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update
    Filipponi, F.
    De Carlis, L.
    Metselaar, H. J.
    Nevens, F.
    Saliba, F.
    Junge, G.
    LIVER TRANSPLANTATION, 2010, 16 (06) : S132 - S133
  • [49] Efficacy and Safety of Everolimus With Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplant: Design of a Randomized Study.
    Grant, D.
    Levy, G.
    Song, G.
    Chen, C.
    Lee, W.
    Joh, J.
    Speziale, A.
    Rauer, B.
    Wang, Z.
    Junge, G.
    Uemoto, S.
    Suh, K.
    TRANSPLANTATION, 2014, 98 : 781 - 782
  • [50] The safety and efficacy of sirolimus and cyclosporine versus tacrolimus in de novo orthotopic liver transplant recipients: Results from a pilot study.
    Wiesner, RH
    HEPATOLOGY, 2001, 34 (04) : 254A - 254A
12345